Tempest Therapeutics, Inc.

1 institutions still hold Tempest Therapeutics, Inc. as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 87978U108·1 13F holders·last filed Mar 31, 2026

Market cap

—

▼ 7.2%

vs prior quarter

13F value held

$442,426

53.0% inst. owned

of float

Holders

-12 QoQ

filers reporting

Activity

+37 / −34

+905 added · −775 reduced

this quarter

Concentration

100.00%

Versant Venture Management, LLC #1

top holder share

AI Holders Summary · Q1 2026

1 institutions reported OVASUSD in Q1 2026. Versant Venture Management, LLC leads at 100.0% of the visible book. -12 net institutions QoQ — distribution reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter

Versant Venture Management, LLC

CIK 0001560009

$442,426270K0.31%Q1 2026